SFG
VRTX icon

SevenBridge Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

SevenBridge Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-465
Closed -$222K – 213
2025
Q4 		$222K Sell
465
-15
-3% -$6.46K 0.04% 191
2025
Q3 		$208K Buy
+480
New +$201K 0.03% 204
2025
Q2 		– Sell
-514
Closed -$226K – 229
2025
Q1 		$226K Sell
514
-485
-49% -$226K 0.04% 206
2024
Q4 		$455K Hold
999
– – 0.09% 151
2024
Q3 		$501K Hold
999
– – 0.1% 145
2024
Q2 		$474K Hold
999
– – 0.1% 138
2024
Q1 		$401K Sell
999
-335
-25% -$142K 0.09% 146
2023
Q4 		$543K Buy
1,334
+175
+15% +$64.6K 0.13% 125
2023
Q3 		$403K Hold
1,159
– – 0.1% 134
2023
Q2 		$408K Sell
1,159
-150
-11% -$50.5K 0.11% 132
2023
Q1 		$412K Sell
1,309
-35
-3% -$10.5K 0.11% 131
2022
Q4 		$388K Sell
1,344
-16
-1% -$4.88K 0.11% 133
2022
Q3 		$394K Hold
1,360
– – 0.13% 119
2022
Q2 		$383K Sell
1,360
-90
-6% -$24.1K 0.15% 101
2022
Q1 		$378K Sell
1,450
-210
-13% -$49.8K 0.13% 112
2021
Q4 		$365K Sell
1,660
-239
-13% -$46.5K 0.11% 128
2021
Q3 		$344K Sell
1,899
-436
-19% -$85.1K 0.11% 124
2021
Q2 		$471K Buy
2,335
+82
+4% +$17.2K 0.15% 112
2021
Q1 		$484K Buy
2,253
+565
+33% +$124K 0.18% 104
2020
Q4 		$399K Buy
+1,688
New +$387K 0.16% 106
2020
Q3 		– Sell
-1,336
Closed -$388K – 141
2020
Q2 		$388K Hold
1,336
– – 0.19% 96
2020
Q1 		$318K Hold
1,336
– – 0.18% 96
2019
Q4 		$293K Hold
1,336
– – 0.08% 124
2019
Q3 		$226K Buy
+1,336
New +$236K 0.12% 128

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SevenBridge Financial Group's VRTX Position: Q1 2026 in Review

SevenBridge Financial Group sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 465 shares — an estimated $222K sold.

SevenBridge Financial Group first reported a position in VRTX in Q3 2019 and held it in 24 quarters. The position peaked at $543K in Q4 2023. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • SevenBridge Financial Group reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • SevenBridge Financial Group sold 465 Vertex Pharmaceuticals shares in Q1 2026, an estimated $222K.
  • SevenBridge Financial Group first reported a position in Vertex Pharmaceuticals in Q3 2019 and held it in 24 quarters.
  • SevenBridge Financial Group's Vertex Pharmaceuticals position peaked at $543K in Q4 2023.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.